
Sign up to save your podcasts
Or


We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
By Retina Synthesis4.5
88 ratings
We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.

43 Listeners

18 Listeners

97 Listeners

112,664 Listeners

56,879 Listeners

5 Listeners

9,572 Listeners

11 Listeners

47,738 Listeners

51 Listeners

11 Listeners

465 Listeners

19 Listeners

0 Listeners